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Mutations in the human LMNA gene, encoding A-type lamins, give rise to laminopathies, which include sev-
eral types of muscular dystrophy. Here, heterozygous sequence variants in LMNA, which result in single
amino-acid substitutions, were identiﬁed in patients exhibiting muscle weakness. To assess whether the sub-
stitutions altered lamin function, we performed in vivo analyses using a Drosophila model. Stocks were gen-
erated that expressed mutant forms of the Drosophila A-type lamin modeled after each variant. Larvae were
used for motility assays and histochemical staining of the body-wall muscle. In parallel, immunohistochem-
ical analyses were performed on human muscle biopsy samples from the patients. In control ﬂies, muscle-
speciﬁc expression of the wild-type A-type lamin had no apparent affect. In contrast, expression of the
mutant A-type lamins caused dominant larval muscle defects and semi-lethality at the pupal stage.
Histochemical staining of larval body wall muscle revealed that the mutant A-type lamin, B-type lamins,
the Sad1p, UNC-84 domain protein Klaroid and nuclear pore complex proteins were mislocalized to the cyto-
plasm. In addition, cytoplasmic actin ﬁlaments were disorganized, suggesting links between the nuclear
lamina and the cytoskeleton were disrupted. Muscle biopsies from the patients showed dystrophic histopath-
ology and architectural abnormalities similar to the Drosophila larvae, including cytoplasmic distribution of
nuclear envelope proteins. These data provide evidence that the Drosophila model can be used to assess the
function of novel LMNA mutations and support the idea that loss of cellular compartmentalization of nuclear
proteins contributes to muscle disease pathogenesis.
INTRODUCTION
Laminopathies comprise a class of human diseases that typic-
ally affect one or more tissues, resulting in cardiomyopathies,
premature ageing syndromes, lipodystrophies, neuropathies,
dermopathies or muscular dystrophies (1). Many genetic sub-
types of muscular dystrophy cause progressive wasting and
degeneration of skeletal muscle (2), including autosomal-
dominant Emery–Dreifuss muscular dystrophy (AD-EDMD)
(3). More than 250 distinct mutations in the ubiquitously
expressed LMNA have been linked to AD-EDMD, yet a
general understanding of the cause and progression of the
disease remains elusive (3,4).
Lamin genes are found in all metazoans, but are absent in
plants and unicellular organisms (5,6). Lamins are classiﬁed
into A and B types, based on their biophysical properties
and expression proﬁles (7–12). In mammals, A-type lamins
(lamins A, C, AD10 and C2) are the products of LMNA tran-
scripts that are alternatively spliced (13–15), whereas B-type
lamins (lamins B1 and B2–B3) are encoded by the
LMNB1 and LMNB2 genes, respectively (16,17). In Drosoph-
ila, A- and B-type lamins are encoded by two genes, Lamin C
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expressed upon differentiation in a wide variety of cell types
(18); in contrast, the B-type lamins are expressed ubiquitously
throughout development (19–21).
Lamins play a structural role by assembling into the lamina
network that underlies the inner nuclear membrane of the
nuclear envelope (NE). Lamins participate in nuclear migra-
tion and positioning, nuclear shape maintenance, nuclear
pore spacing, chromatin organization, chromosome segrega-
tion, gene expression, signal transduction and cytoskeletal or-
ganization (13,22–29). In addition to their peripheral
localization, lamins are components of supramolecular com-
plexes residing at the nucleus interior (30), where they play
a role in retinoblastoma-mediated cell proliferation (31,32)
and the initiation of DNA replication (33). Given that the
A-type lamins are nearly ubiquitously expressed and partici-
pate in so many different cellular processes, it is challenging
to explain the cellular and molecular mechanisms by which
mutant forms contribute to tissue-speciﬁc pathology. The lit-
erature describes several non-mutually exclusive models to
explain this paradox (34,35). (1) The ‘mechanical stress’ hy-
pothesis proposes that mutations in LMNA give rise to a wea-
kened nuclear envelope, predisposed to damage (35). (2) The
‘gene regulation’ hypothesis proposes that disruptions in the
nuclear lamina prevent proper associations with chromatin,
causing misregulation of gene expression (35). (3) A newly
emerging hypothesis proposes that the A-type lamins regulate
tissue homeostasis (36). In this model, the disease-causing
mutants in the A-type lamins are suggested to perturb the
balance between proliferation and differentiation in adult
stem cells, thereby compromising tissue regeneration
(37,38). All three models are mutually compatible, which
might explain why it has been challenging to determine the
exact mechanism by which the mutant lamins cause muscle
disease.
This study focused on three non-related pediatric patients
exhibiting muscle weakness characteristic of muscular dys-
trophy. Each patient harbored a heterozygous nucleotide sub-
stitution in LMNA that resulted in an amino-acid substitution
within the A-type lamin. However, it was unclear whether
these substitutions were polymorphisms or pathogenic. To
test the hypothesis that these variants disrupt lamin function
and to reveal potential disease mechanisms, we modeled the
substitutions (and a known AD-EDMD-causing substitution)
in the Drosophila lamin. Our studies revealed novel molecular
defects that occurred upon expression of mutant lamins, which
were then conﬁrmed using human muscle biopsy tissue.
RESULTS
Three patients with muscular weakness harbor amino-acid
substitutions in the Ig-fold domain of the A-type lamin
Previous studies described amino-acid substitutions within the
Lamin A/C Ig-fold domain that resulted in muscular dystrophy
(3,4). We identiﬁed three patients with muscle atrophy that
harbored heterozygous variant alleles of LMNA (Table 1).
Each variant was predicted to cause a novel amino-acid substi-
tution in the Ig-fold domain (G449V, L489P and W514R; see
Table 1). These point mutations were not reported in the
Leiden Muscular Dystrophy Database (http://www.dmd.nl/),
which catalogs LMNA mutations associated with muscular
dystrophy. Whether these variants were silent or pathogenic
was unknown, and how they might alter the Ig-fold structure
and lamin function was not obvious. There was no test to
assay the function of lamin variants in vivo. To determine
whether the variants we identiﬁed might be pathologic muta-
tions causing LMNA-associated muscular dystrophy, we used
a Drosophila model (39,40).
Drosophila is the only widely used invertebrate model that
expresses endogenous A- and B-type lamins homologous to
those in humans. Furthermore, Drosophila express a single
A-type lamin—Lamin C. Two of the substitutions (G449 and
L489) discovered in the patients were in residues conserved
between human Lamin A/C and Drosophila Lamin C (G489
and V528); the third amino acid (W514) is not conserved in
Drosophila Lamin C (M553), however, it resides within a con-
served stretch of amino acids (Fig. 1A). The position of each
amino acid is indicated in the known structure of the Ig-fold
(41) (Fig. 1B). In addition, we modeled N496I (N456I), a
known AD-EDMD-causing substitution as a ‘positive control’
(42). We generated transgenic Drosophila stocks expressing
versions of the Drosophila A-type lamin that were homologous
to the patient Lamin A/C variants and the known disease-
causing mutant under control of the Gal4/UAS system (43).
Modeling human lamin mutations in Drosophila revealed
muscle defects
The amino-acid substitutions, which appeared to have a dom-
inant effect in the patients, were tested for a dominant effect in
a Drosophila model system. The three variant forms of
Lamin C, the ‘positive control’ and wild-type Lamin C were
expressed in different tissues of transgenic ﬂies in an other-
wise wild-type genetic background. Tissue-speciﬁc expression
was achieved using the Gal4/UAS system and a series of
‘driver’ stocks that express Gal4 in speciﬁc tissues (44).
Thus, the various forms of Lamin C could be expressed ubi-
quitously, or speciﬁcally in eye discs (negative control), or
muscle tissue of embryos, larvae and adults (Table 2).
Wild-type Lamin C, expressed by any of the Gal4 drivers
tested, did not decrease viability or results in any visible
phenotype (Table 2). Likewise, no effects were observed
upon expressing that altered forms of A-type lamin in non-
muscle tissue such as eye discs. No effects on viability were
seen upon expression in adult muscle; however, a thorough
analysis of adult muscle function was not undertaken. In
Table 1. Genetic lesions in LMNA and age of onset for muscle atrophy
Nucleotide change Exon Amino-acid change Age of onset
1072G.A
a 6 N456I 9
1346G.T 7 G449V 3
1466T.C 8 L489P 7
1540T.C 9 W514R 5
aAn AD-EDMD mutation described in Ref. (42).
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three variants were expressed in muscle of late embryos and
larvae (using either the C57 or MEF2 promoters). Approxi-
mately 70–95% of the expected progeny died at the late
pupal stage. The percent lethality depended upon which
mutant was expressed; N496I gave the least amount of
death, and G489V caused complete lethality. Examination of
the developing pupae revealed mutant phenotypes that
included short, kinked legs and a gas bubble that remained
at the bottom of the pupal case—phenotypes exhibited by
known muscle mutants (45) (Table 2). The ‘escaper’ adults
that managed to live past the pupal stage showed adult leg
defects: the last tarsal segments were twisted and shorter—a
phenotype nearly identical to that observed in ﬂies expressing
a ‘headless’ Lamin C (44). We conﬁrmed that these mutant
phenotypes were not simply due to over-expression of the
A-type lamin variants, as western analysis showed that the
wild-type Lamin C (which had no effect) and mutant variants
were expressed at similar levels (Supplementary Material,
Fig. S1).
The decreased viability, pupal defects and late pupal death
caused by expressing the lamin variants in late embryonic/
larval muscle suggested that the amino acids altered are im-
portant for larval muscle function. To directly test muscle
function, we performed locomotion assays in which larval
crawling was recorded over 2-min intervals (Fig. 2). Wander-
ing, third-instar larvae were placed at the center of a Petri dish
sectored into concentric zones and their movement measured
after 2 min. Larvae expressing wild-type Lamin C crawled
to zone 3, whereas the larvae expressing the mutant forms
remained in zone 1. These assays clearly show that Drosophila
expressing the A-type lamins characteristic of human muscle
disease have reduced mobility (Fig. 2).
Amino-acid substitutions in the Ig-fold domain of A-type
lamins cause both A- and B-type lamins to mislocalize
These locomotion defects prompted us to examine the
muscle tissue in the transgenic larvae at the cellular level.
Using indirect immunoﬂuorescence, the larval body wall
muscle was stained with antibodies recognizing Lamin C
and lamin Dm0 (the Drosophila B-type lamin). In larvae
expressing wild-type lamin, staining showed myonuclei
localized in an evenly spaced pattern at the periphery of
the ﬁber (Fig. 3A). Myonuclei also appeared normal in
Drosophila expressing the N456I Lamin C mutant that is
homologous to the A-type lamin previously linked to
AD-EDMD (Fig. 3A and B). In contrast,  30% of the
Figure 1. Ig-fold domain of human and Drosophila A-type lamins. (A) Alignment of the Ig-fold domain of human Lamin A/C (Hs) and Drosophila Lamin C
(Dm), using BLAST (bl2seq, NIH). One of the amino acids affected in the patient cases (G449) is identical between the two species; the second amino acid is
similar (L489) and the third amino acid is not conserved (W514) but is ﬂanked by conserved residues. Amino acid N456 is known to cause AD-EDMD when
substituted with I. (+) Conserved residue based on similar amino-acid structure; (2) Gap in amino-acid sequence. (B) Ribbon diagram of the human Lamin A/C
Ig-like fold (PDB: 1IFR) showing the relative position of the amino acids affected in patient cases studied here.
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A-type lamin mutants showed the myonuclei aggregated.
The nuclei were comparable in size to those in larvae that
expressed wild-type Lamin C. The average diameter of 30
nuclei expressing wild-type Lamin C was 7.8 + 0.5 mm,
similar to 7.2 + 0.9 mm obtained for nuclei expressing
mutant Lamin C. Both A- and B-type lamins remained ex-
clusively nuclear in the wild-type control and N496I larvae
(Fig. 3A and B). In contrast, the three Lamin C mutants
modeled after our patients showed A- and B-type lamins
localized in a punctate, non-nuclear pattern in  30% of
the myoﬁbers (Fig. 3A and B). These defects did not
appear due to developmental abnormalities. We analyzed
the larval body wall muscle of ﬁrst and second instar
larvae and found no such defects (data not shown). Thus,
the mislocalization is likely the result of accumulation of
mutant Lamin C and/or increased mechanical stress experi-
enced during the third instar stage.
Amino-acid substitutions in the Ig-fold domain cause
non-nuclear localization of SUN domain and nuclear
pore proteins
To determine whether the localization defects were restricted
to lamins, we examined the localization of Klaroid (46).
Klaroid is a Sad1p, UNC-84 (SUN) domain-containing
protein that is required for proper nuclear migration and local-
ization of Klarsicht [a Klarsicht, ANC-1, Syne homology
domain-containing protein] to the nuclear envelope (46). In
larvae expressing wild-type Lamin C or the N496I mutant,
Klaroid staining exhibited the expected rim-like pattern
around the myonuclei (Fig. 4A). In contrast, expression of
G489V, V528P and M553R showed cytoplasmic localization,
with apparent enrichment immediately outside the nucleus
(Fig. 4). Thus, A-type lamin Ig-fold substitutions lead to cyto-
plasmic mislocalization of an inner nuclear envelope protein.
To determine whether mislocalization was conﬁned to inner
nuclear envelope proteins or also affected other proteins asso-
ciated with the nuclear envelope, the localization of two differ-
ent types of nuclear pore components (NPCs) was determined.
Antibodies that recognize FG-repeat-containing nucleoporins
(47) stained the nuclear periphery in the wild-type control
and N496I mutant. In contrast, the other Ig-fold amino-acid
substitutions caused the FG-repeat-containing proteins to be
distributed broadly throughout the cytoplasm of a myoﬁber
(Fig. 5A). A nearly identical pattern was observed with anti-
bodies to GP210, a trans-membrane NPC (Figs 4B and 5B)
(48). These data suggest that the amino-acid substitutions
found in our patients alter the lamin network, causing miscom-
partmentalization of NPC protein.
To determine whether the unusual cytoplasmic distribution
of proteins was limited to those of the nuclear envelope or also
affected chromatin proteins, antibodies to Heterochromatin
Protein 1a (HP1a) were tested (49). HP1 proteins are enriched
in heterochromatic regions, which are juxtaposed to the
nuclear envelope, and display dynamic association with chro-
matin (50–54). In all larvae tested, staining with antibodies
against HP1a revealed normal heterochromatin organization
(Supplementary Material, Fig. S2), suggesting that not all
nuclear proteins were affected.
Patient muscle biopsies and transgenic larvae share similar
myoﬁber and nuclear defects
Muscle from transgenic Drosophila larvae was compared with
skeletal muscle biopsies from the patients in whom the LMNA
mutations were originally identiﬁed (Table 1). Cross-sections
Table 2. Tissue-speciﬁc expression of wild-type and mutant forms of Lamin C
Lamin Eyeless (eye discs) C57 (embryo/larval muscle) Mef2 (embryo/larval muscle) MHC (adult muscle)
wt Viable Viable Viable Viable
G489V (G449V) Viable Semi-lethal Lethal Viable
N496I (N456I) Viable Semi-lethal
a, LD, PD Lethal Viable
V528P (L489P) Viable Semi-lethal
a, LD, PD Lethal Viable
M553R (W514R) Viable Semi-lethal
a, LD, PD Semi-lethal
a, PD Viable
Human residues in parentheses. LD, leg defect; PD, pupal defects.
aSemi-lethal: 70–95% lethality.
Figure 2. Mutant forms of Lamin C cause locomotion defects. The results
from locomotion assays of larvae expressing Lamin C transgenes by the
C57 Gal4/UAS driver are shown. Three independent assays were performed
using eight similarly staged larvae each. Box plots display 25–75 percentile
range of the data and the thick black line indicates the median value. The
Y-axis represents zones outlined in a Petri dish containing agarose. The
X-axis shows the mutant form of Lamin C expressed in larvae.
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escence using antibodies against Lamin A/C, Lamin B1, dys-
trophin (a marker of the muscle cell membrane) and
4′,6-diamidino-2-phenylindole (DAPI, which stains DNA). In
muscle biopsies from healthy controls as well as patients,
staining for both A- and B-type lamins decorated the periphery
of myoﬁber nuclei (Fig. 6A and B). Dystrophin immunoﬂuor-
escence illustrates the normal variation in muscle ﬁber dia-
meters in controls and the wide variation in diameters,
ranging from atrophic to hypertrophic, characteristic of mus-
cular dystrophies in the patient samples (Fig. 6A and B). In
addition, control biopsies show myonuclei localized in the
normal, eccentric, subsarcolemmal position. In contrast,
patient samples reveal some muscle ﬁbers with internally
placed myonuclei (Fig. 6A and B), which is commonly seen
in myoﬁbers that have undergone necrosis and regeneration.
As the transgenic Drosophila displayed myonuclear
defects, the myonuclei were examined in patient biopsies.
In myonuclei from healthy individuals, SUN2 localized at
the nuclear periphery (Fig. 7A, control); but in patient biop-
sies, a fraction of the myoﬁbers ( 0.5%) contained SUN2
aggregating at non-nuclear sites (Fig. 7A). Likewise,
control samples showed that the FG-repeat NPCs localized
at the nuclear periphery. However, in up to 0.5% of the
muscle ﬁbers examined from patient tissue, anti-nuclear
pore protein staining was also cytoplasmic, similar to
what had been observed in the Drosophila muscle
(Fig. 7B). The NPC protein formed foci of various sizes
and ﬂuorescent intensity (Fig. 7B).
To our knowledge, this unusual localization of NPCs has
not been reported for LMNA-related muscular dystrophies.
We wondered whether cytoplasmic NPC staining could be
due to myoﬁber damage and cell necrosis. This hypothesis
was tested in human biopsies by simultaneously staining
with antibodies against NPCs and dystrophin (Fig. 8). The
analysis revealed that dystrophin staining in myoﬁbers with
cytoplasmic NPCs (average of 10 ﬁbers gave 240 + 8 arbi-
trary units) was similar to that of ﬁbers without cytoplasmic
NPCs (average of 30 ﬁbers gave 247 + 3 arbitrary units).
Fiber integrity was also tested in the Drosophila muscle by
staining larval body wall muscle from transgenic ﬂies expres-
sing wild-type and mutant Lamin C with Evans Blue dye,
which only penetrates cells in which the membrane is dis-
rupted. Muscle cells of both genotypes showed no blue stain-
ing, indicating that the muscle ﬁbers were intact, whereas
injured control cells showed intense blue staining (data not
shown). Thus, analysis of biopsies from patient muscle
revealed that SUN domain and NPCs were miscompartmenta-
lized in intact muscle ﬁbers, a remarkably similar observation
to that observed in the Drosophila model.
Figure 3. Expression of mutant forms of Lamin C in larval muscle causes mislocalization of A- and B-type lamins, nuclear and cytoskeletal defects. Staining of
third instar larval body wall muscle ﬁllets with anti-Lamin C (A, green), anti-lamin Dm0 (B, green), phalloidin (A and B, purple) and DAPI (A and B/merge,
blue) from larvae expressing wild-type Lamin C (wild-type) or mutant Lamin C transgenes by the muscle-speciﬁc driver C57. Drosophila amino-acid numbers
are shown with human amino acid numbering in parentheses. Bar, 10 mm.
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cases of LMNA-related muscular dystrophy, we examined
tissues from additional AD-EDMD patients in which muta-
tions affected the rod domain (R541K) or the Ig-fold
(E358K, R541P and R453W). To determine whether NPC
mislocalization was speciﬁc for LMNA-related muscular dys-
trophies, we examined tissues from patients with muscle
disease not due to mutations in LMNA, namely Duchenne
muscular dystrophy (DMD) and facioscapulohumeral muscu-
lar dystrophy (FSHD). Muscle tissues were stained with anti-
bodies to FG-repeat-containing NPCs, phalloidin and DAPI,
and 600–1000 muscle ﬁbers per sample were examined.
Again, control samples showed normal localization of the
nuclear pore proteins; no detectable signal appeared outside
the myonuclei of the muscle ﬁbers (Fig. 9). In contrast, both
LMNA-mutated samples (E358K and R541P, Lamin A/C
mutations) contained a small percentage (up to 0.5%) of myo-
ﬁbers with cytoplasmic NPCs, similar to our three new patient
mutations. Both non-LMNA-associated muscular dystrophies
did not show this phenotype. Thus, we propose that the NPC
localization defect is not conﬁned to amino-acid substitutions
within the Ig-fold and might be a general feature of
LMNA-associated muscular dystrophies.
DISCUSSION
Drosophila as a model for testing novel LMNA mutations
We have developed a Drosophila model for the study of
human laminopathies. This model is possible in part,
because Drosophila (unlike other invertebrate model organ-
isms) possess the A- and B-type lamins found in humans
Figure 4. Expression of mutant forms of Lamin C in larval muscle causes mislocalization of Klaroid. Staining of third instar larval body wall muscle ﬁllets with
anti-Klaroid (green), phalloidin (purple) and DAPI (merge, blue) from larvae expressing wild-type Lamin C (wild-type) or mutant Lamin C transgenes by the
muscle-speciﬁc driver C57. Drosophila amino-acid numbers are shown with human numbers in parentheses. Bar, 10 mm.
Human Molecular Genetics, 2012, Vol. 21, No. 7 1549(11,39,55). Moreover, 70% of the amino-acid residues altered
in laminopathies affect residues conserved in the Drosophila
A-type lamin. All of the Ig-fold variants tested here caused
dominant muscle defects, similar to laminopathies in
humans, suggesting that Drosophila can be used to assay the
function of novel sequence variants for their pathogenicity.
The Drosophila model can also be used to provide insights
on the mysteries surrounding the molecular defects caused by
mutant lamins. The availability of larval muscle allows for
relatively quick and easy cytological and biochemical analyses
of candidate proteins. For example, a collection of antibodies
could be used to assay for protein mislocalization, and the key
ﬁndings validated using the limited human tissue. This ap-
proach rapidly led us to the identiﬁcation of SUN2 and
nuclear pore proteins in the cytoplasm of the patients, which
might be useful as a histochemical marker for
LMNA-associated muscle disease (Fig. 7).
It is unclear as to how mutant lamins cause muscle disease.
The Ig-fold mutant N496I (known to cause AD-EDMD) had
relatively little effect on nuclear shape, location and nuclear
envelope protein cellular compartmentalization (Figs 3–5),
yet it caused locomotion defects and lethality at the pupal
stage (Fig. 2 and Table 2). Expression of the Ig-fold variants
discovered in the three patients caused nearly an identical
locomotion defect and stage of death, yet had gross cellular
defects in  30% of muscle ﬁbers (Figs 3–5). These data
suggest that different substitutions exhibit a range of pheno-
types, yet all converge on lethality, and that the Drosophila
expression system might provide a means of classifying
newly isolated substitutions.
Contributions of the Ig-fold to LMNA-associated pathology
Lamins play critical roles in nuclear structure, shape, mechan-
ical stability and chromatin organization (56,57) and in doing
so, they interact with numerous proteins in the nuclear enve-
lope and nucleoplasm (58). Proteins within the inner mem-
brane appear to rely on the lamin network for stable
association (59–62). The three pathogenic amino-acid substi-
tutions we identiﬁed in Lamin A/C—G449V, L489P and
W514R—are located in AB, C’E and EF loops of the
Ig-fold, respectively (41) (Fig. 1B). L489 contacts residues
of the two main b sheets, stabilizing the b sandwich and the
positioning the BC and C’E loops. The W514 residue, along
with other residues (W520 and W498), likely plays a role in
positioning of the loop b7b8( 41). G449 lies within the AB
loop, the most ﬂexible loop region that is the least well
deﬁned within the Ig-fold structure. Replacement of G449
by the bulkier and hydrophobic V might destabilize the
Ig-fold structure. This idea is supported by the fact that the
Figure 5. Expression of mutant forms of Lamin C in larval muscle causes mislocalization of nuclear pore proteins. Staining of third instar larval body wall
muscle ﬁllets with an antibody that recognizes nuclear pores possessing an FG-repeat (A, green), and the nuclear pore protein GP210 (B, green), phalloidin
(A and B, purple) and DAPI (A and B/merge, blue) from larvae expressing wild-type Lamin C (wild-type) or mutant Lamin C transgenes by the muscle-speciﬁc
driver C57. Drosophila amino-acid numbers are shown with human numbering in parentheses. Bar, 10 mm.
1550 Human Molecular Genetics, 2012, Vol. 21, No. 7apparent melting temperature of this Ig-fold variant is dramat-
ically less than that of the wild-type Ig-fold (O. Shresthna and
L.L.W., unpublished). As the Ig-fold is known to interact with
other proteins, amino-acid substitutions at these residues might
affect the Ig-fold structure in such a way so as to disrupt
crucial interactions with these proteins.
The new mutations we identiﬁed might disrupt (a)
polymerization or association/dissociation kinetics, (b)
post-translational modiﬁcations of A-type lamins or (c)
protein–protein interactions. It is worth pointing out that the
Ig-fold domain is the site of many partner associations (63).
The C-terminal SUN domain of both Sun1 and Sun2 project
into the perinuclear space, whereas their N-terminal region is
nucleoplasmic and interacts directly with the Ig-fold of A-
and B-type lamins (64–68). Lamins also interact with Nup88
and Nup153 through a region containing the Ig-fold (69,70).
Connections with the Ig-fold might play a role in anchoring
these proteins or complexes containing these proteins.
Altered cellular compartmentalization as a disease
mechanism
Loss of cellular compartmentalization was recently observed
in primary ﬁbroblasts from patients with laminopathies (71).
In these cases, transcription factors normally enriched in the
cytoplasm or the nucleus under deﬁned conditions were
observed in the incorrect cellular compartment. Improper lo-
calization appeared to be caused by transient, non-lethal,
rupture of the nuclear envelope. Imaging data in the literature
support the notion of nuclear envelope rupture in conjunction
with mutant lamins. Electron microscopy (EM) images of
tissue from patients with muscle-speciﬁc laminopathies show
dilated perinuclear space, regional absence of lamina and ex-
trusion of chromatin from the nucleus (71–73). In addition,
EM images of Drosophila Lamin C null larvae show similar
results including regional discontinuity between the inner
and outer nuclear membranes and large ‘holes’ in the
nuclear envelope (39). Therefore, rupture of the nuclear enve-
lope could explain the appearance of SUN domain proteins
and nuclear pores within the cytoplasm, as released fragments
of the NE or miscompartmentalization of the proteins during
membrane rupture.
MATERIALS AND METHODS
Site-directed mutagenesis
Constructs encoding the mutant forms of Drosophila Lamin C
were generated using the Quick Change II Site Directed Mu-
tagenesis Kit (Agilent Technologies, Santa Clara, CA, USA).
The sequences of the PCR primers used for mutagenesis
were as follows:
G489V forward, 5′-GGCGGACGTTGAGGTACGCTTCA
TCAAGCTGC-3′; G489V reverse, 5′-GCAGCTTGATGAA
GCGTACCTCAACGTCCGCC-3′; N496I forward, 5′-GCTT
CATCAAGCTGCACATCAAGGGAACCGAGGAG-3′;
N496I reverse, 5′-CTCCTCGGTTCCCTTGATGTGCAGCTT
Figure 6. Dystrophic features in human patient skeletal muscle biopsies. Staining of human muscle biopsies from healthy individuals (control) or novel LMNA
mutation patients (G449V, L489P, W514R) with anti-Lamin A/C (A, green), anti-Lamin B1 (B, green), anti-dystrophin (A and B, purple) and DAPI (A and B,
blue). Bar, 10 mm.
Human Molecular Genetics, 2012, Vol. 21, No. 7 1551GATGAAGC-3′; V528P forward, 5′-CGCGCGGATCGAAG
CCACTCGGCGGTGCTAGTG-3′; V528P reverse, 5′-CAC
TAGCACCGCCGAGTGGCTTCGATCCGCGCG-3′; M553R
forward, 5′-CCCAACAATCGGTGCGGAAGAAGAAGTGG
CCG-3′; M553R reverse, 5′-CGGCCACTTCTTCTTCCG
CACCAGATTGTTGGG-3′.
The primers contain nucleotide substitutions that result in
single amino-acid substitutions within Lamin C. The
mutated Lamin C sequences were cloned into the
P-element transformation vector pUAST (74) and used to
generate transgenic stocks.
Drosophila stocks and genetic analyses
Drosophila stocks were raised at room temperature on stand-
ard sucrose and cornmeal medium (75). Generation of trans-
genic stocks expressing wild-type and Lamin C DN was
previously reported (39,40). The GAL4-UAS system (43,74)
was used to drive expression of wild-type and mutant forms
of Lamin C in speciﬁc tissues. The GAL4 driver stocks used
in this study were obtained from the Bloomington Stock
Center (Act5C, Eyeless, MEF2) and a gift from W. Maddox
(MD Anderson Cancer Center) (MHC) and a gift from
Figure 7. Mislocalization of SUN2 and nuclear pore proteins in human patient skeletal muscle biopsies. Staining of human muscle biopsies from healthy indi-
viduals (control) or novel LMNA mutation patients (G449V, L489P, W514R) with anti-SUN2 (A, green), antibodies to nuclear pore proteins possessing FG
repeats (B, green), phalloidin (A and B, purple) and DAPI (A and B, blue). Areas boxed in yellow are shown as enlargements below. Arrowheads indicate cyto-
plasmic localization of SUN2 and FG-repeat containing proteins in skeletal muscle ﬁbers. Bar, 10 mm.
1552 Human Molecular Genetics, 2012, Vol. 21, No. 7V. Budnik (Department of Neurobiology, University of Mas-
sachusetts, Worcester, MA, USA) (76).
Immunostaining of muscles
Larval muscle preparations were performed according to the
published procedures (77). After ﬁxation, the dissected body
wall preparations were blocked in PBS2+ (130 mM NaCl,
7m M Na2HPO4,3m M NaH2PO4,1 0m M ethylene glycol tetra-
acetic acid, 0.1% Triton-X 100) containing 0.1% bovine serum
albumin (BSA) for 1 h. Muscle preparations were stained with
66 nM ﬂuorescent Phalloidin (Alexa Fluor 488 from Molecular
Probes) in PBS2+ containing 0.1% BSA, rat anti-tyrosinated
tubulin (1:50 dilution). Peripheral nuclear pore proteins were
detected using MAb414 (anti-mouse, 1:3000 dilution;
Covance; recognizes the FXFG repeat sequence in nucleopor-
ins, a related family of NPC proteins including p62, p152 and
p90) and transmembrane nuclear pore protein GP210 was
detected using AGP26.10 (anti-mouse, 1:50 dilution) obtained
from the University of Iowa Hybridoma Core facility. Klaroid
was detected using rat anti-Klaroid (1:20 dilution; anti-Koi, a
generous gift from J. Fischer, University of Texas, Austin, TX,
USA). Drosophila Lamin C was detected using LC28.26 (anti-
mouse, 1:400 dilution), Drosophila lamin Dm0 using
ADL84.12 (anti-mouse, 1:400 dilution) and Drosophila
HP1a using C1A9 (anti-mouse, 1:100 dilution) obtained
from the University of Iowa Hybridoma Core facility.
Imaging was performed on a Bio-Rad MRC 1024 confocal
Figure 8. Intact myoﬁbers showing mislocalization of nuclear pore complexes
in human patient skeletal muscle biopsies. Staining of human muscle biopsies
from healthy individuals (control) or novel LMNA mutation patients (G449V,
L489P, W514R) with antibodies that recognize nuclear pore proteins posses-
sing FG repeats (green), anti-dystrophin (purple) and DAPI (blue). Areas
boxed in yellow are enlarged below. Asterisks indicate cytoplasmic localiza-
tion of NPCs in skeletal muscle ﬁbers. Bar, 10 mm.
Figure 9. Mislocalization of nuclear pore proteins in AD-EDMD, but not other
types of MD patients. Staining of human muscle biopsies from healthy indivi-
duals (pediatric and adult control) or patients with LMNA mutations causing
AD-EDMD (E358K/rod, R541P/Ig-fold), LGMD (R453W/Ig-fold), DMD or
FSHD with antibodies that recognize nuclear pores possessing FG repeats
(green), phalloidin (purple) and DAPI (blue). Area boxed in yellow shows
cytoplasmic distribution of nuclear pore proteins. Bar, 10 mm.
Human Molecular Genetics, 2012, Vol. 21, No. 7 1553microscope (Center for Microscopy, University of Iowa, IA,
USA).
For immunohistochemistry of human tissue, quadriceps
muscle biopsies were performed. Each patient sample
showed evidence of necrotizing myopathy: scattered muscle
ﬁbers undergoing myonecrosis or regeneration without
lymphocytic inﬂammatory inﬁltrates. A mixture of atrophic
and hypertrophic ﬁbers was present. Immunoﬂuorescence
studies for the dystrophin–glycoprotein complex and
merosin were normal in all biopsies. Collagen VI was
normal in the patients with L489P and W514R variants. A
mild basement membrane reduction in collagen VI immunos-
taining was detected in the biopsy from the patient with the
G449V variant. However, evaluation of ﬁbroblast cultures
from this patient revealed normal collagen VI synthesis and
secretion, and no mutations in the COL6 gene.
Western analysis
To determine the expression levels of Drosophila Lamin C,
proteins were extracted from third instar larvae (78) and sepa-
rated by size on 10–12% polyacrylamide gels, transferred to
nitrocellulose membrane and incubated with anti-Lamin C
LC28.26 anti-mouse IgG (11) used at 1:5000–1:8000 dilution
or anti-alpha tubulin anti-mouse IgG1 [Sigma (St. Louis) no.
T5168] used at 1:400 000 dilution. A horseradish peroxidase-
conjugated anti-mouse IgG [Pierce (Rockford, IL, USA) no.
31446] used at a 1:20 000 dilution served as a secondary anti-
body. Detection was carried out using the SuperSignal West
Pico chemiluminescent substrate (Pierce no. 34080). Signal
from the membranes was collected from an Epi Chemi II dark-
room unit ﬁtted with a CCD camera (UVP, San Gabriel, CA,
USA) and the resulting data were quantiﬁed using LabWorks
Image Acquisition software (UVP) and/or Image J software
(http://rsb.info.nih.gov/ij/). Three independent protein isola-
tions were performed for each genotype.
Larval motility assays
Flies expressing wild-type or mutant forms of Lamin C were
crossed to the C57 driver (76) and the resulting third instar
larvae were used for analysis. Eight larvae per experiment
were rinsed with ddH2O and allowed to acclimate on a 1.5%
agarose Petri plate for 10 min. The larvae were placed at the
center of a 1.5% agarose Petri plate with four 1-in. concentric
circles representing four zones and allowed to wander. After
2 min, total larvae in each circle were recorded. Data are dis-
played in a box plot using the computer program ‘R’ (79).
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Supplementary Material is available at HMG online.
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